Key Takeaways
- Federal Minister Syed Mustafa Kamal highlights investment opportunities.
- Invites Chinese companies to partner with Pakistani firms.
- B2B platform proposed for enhanced collaboration.
Federal Minister for National Health Services, Regulations and Coordination, Syed Mustafa Kamal, has called for increased foreign investment in Pakistan’s pharmaceutical sector. Speaking at a recent event, Kamal emphasized the potential for significant returns on investment, particularly for Chinese companies.
In his statement, Kamal stated: 'Pakistan offers substantial opportunities for investment in the pharmaceutical industry and we are keen to see more collaboration between our countries.' This call comes as part of broader efforts by the Pakistani government to attract foreign direct investment (FDI) into key sectors, including healthcare and manufacturing.
Kamal further elaborated on the benefits available to investors, highlighting the country’s strategic location, skilled workforce, and growing demand for pharmaceutical products. He noted that Pakistan has a population of over 220 million people, providing a large market for pharmaceutical goods and services.
The minister also mentioned the importance of leveraging existing platforms such as the B2B investment platform to facilitate smoother business transactions between Pakistani and Chinese companies. 'We are committed to creating an enabling environment where both parties can thrive,' he added, stressing the need for mutual cooperation and shared growth.
According to Kamal, the pharmaceutical sector in Pakistan is poised for significant development, with a focus on research and innovation. The government has already taken steps to modernize regulatory frameworks and improve infrastructure, making it more attractive for foreign investors.
Chinese companies have shown interest in this sector due to its potential for high returns and the growing demand for healthcare services in Pakistan. Several Chinese firms are currently exploring opportunities within the pharmaceutical industry, with a particular focus on areas like drug manufacturing and distribution.
The minister’s call for investment comes at a time when Pakistan is looking to diversify its economy and reduce reliance on traditional industries. The pharmaceutical sector is seen as a key area for growth, capable of creating jobs and contributing significantly to GDP.
'Pakistan offers substantial opportunities for investment in the pharmaceutical industry and we are keen to see more collaboration between our countries.'
Syed Mustafa Kamal, Federal Minister for National Health Services, Regulations and Coordination
